CLINICAL_TRIALS
trial_result
· 2014-09-01
Clinical Trial Update: Pharmacokinetics, Efficacy and Tolerability of BIA 2-093 [Phase 2]
Summary
Phase 2 clinical trial update on pharmacokinetics, efficacy, and tolerability of BIA 2-093 in epilepsy completed with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bial - Portela C S.A. | Conditions: Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2014-09-01